Page 50 - _NIPER-G Annual Report 2019-201
P. 50

Research Area-1

               Abietic  acid  attenuates  RANKL  induced  osteoclastogenesis  and  inflammation
               associated osteolysis by inhibiting the NF‐KB and MAPK signaling
               Osteoporosis is a major debilitating cause of fractures and decreases the quality of life in
               elderly  patients.  Bone  homeostasis  is  maintained  by  bone  forming  osteoblasts  and  bone
               resorpting  osteoclasts. Substantial  evidences  have  shown  that targeting  osteoclasts  using
               natural products is a promising strategy for the treatment of osteoporosis. In the current study,
               we investigated the osteoprotective effect of Abietic acid (AA) in in vitro and in vivo models of
               osteolysis.  In  vitro  experiments  demonstrated  that,  AA  suppressed  receptor  activator  of
               nuclear factor-kappa B ligand (RANKL)-induced osteoclastogenesis and F-actin ring formation
               in  a  concentration  dependent  manner.  Mechanistically,  AA  abrogated  RANKL-induced
               phosphorylation of IKKα/β (ser176/180), IkBα (ser 32), and inhibited the nuclear translocation
               of NF-κB.We also found that, AA attenuated the RANKL-induced phosphorylation of MAPKs
               and decreased the expression of osteoclast specific genes such as TRAP, DC-STAMP, c-
               Fos, and NFATc1. Consistent with in-vitro results, in vivo Lipoploysaccharide (LPS)-induced
               osteolysis model showed that AA inhibited the LPS-induced serum surge in cytokines TNF-α
               and IL-6. μ-CT analysis showed that AA prevented the LPS-induced osteolysis. Furthermore,
               histopathology  and  TRAP  staining  results  suggested  that  AA  decreased  the  number  of
               osteoclasts in LPS-injected mice. Taken together, we demonstrated that the osteoprotective
               action of AA is coupled with the inhibition of NF-κB and MAPK signaling and subsequent
               inhibition of NFATc1 and c-Fos activities. Hence, AA may be considered as a promising drug
               candidate for the treatment of osteoporosis.
               Thummuri D, Guntuku L, Challa VS, Ramavat RN, Naidu VG. Abietic acid attenuates RANKL
               induced osteoclastogenesis and inflammation associated osteolysis by inhibiting the NF‐KB
               and MAPK signaling. Journal of cellular physiology. 2019 Jan;234(1):443-53.


                   Graphical Abstract





























                Figure : RAW 264.7 cells were incubated with RANKL (100 ng/ml) and AA (80 μM) for 5 days. After
                                      fixing the cells F-actin ring staining was performed.



                 NIPER-G                                                                          47
   45   46   47   48   49   50   51   52   53   54   55